Insider · CIK 0001614780

Farfel Gail M

Reports to the SEC for 5 companies · RADNOR, PA

sec.gov

Transactions

Companies

Filings

CIK

0001614780

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-09-11	DURECT CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,500 sh	—	—	0
2025-09-11	DURECT CORPU Disposition from Tender	Director	UDisposition from Tender	−15.5K sh	—	—	0
2025-09-11	DURECT CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2025-09-11	DURECT CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,500 sh	—	—	0
2025-09-11	DURECT CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,500 sh	—	—	0
2025-09-11	DURECT CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,500 sh	—	—	0
2025-09-10	DURECT CORPM Exercise/Conversion	Director	MExercise/Conversion	+5,500 sh	$1.22	+$6,710	15,500
2025-09-10	DURECT CORPStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,500 sh	—	—	0
2024-09-25	DURECT CORPStock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2023-08-23	PMNProMIS Neurosciences Inc.A Award	Director, Chief Executive Officer	AAward	+53.2K sh	—	—	55,192
2023-08-23	PMNProMIS Neurosciences Inc. · Warrants to purchase Common SharesA Award	Director, Chief Executive Officer	AAward	+53.2K sh	—	—	53,192
2023-06-21	DURECT CORPStock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2023-06-06	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.6K sh	—	—	17,643
2022-12-14	PMNProMIS Neurosciences Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,000 sh	$4.94	+$4,940	2,000
2022-12-06	PMNProMIS Neurosciences Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,000 sh	$5.70	+$5,700	1,000
2022-09-19	PMNProMIS Neurosciences Inc. · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+208K sh	—	—	208,334
2022-06-15	DURECT CORPStock Option (right to buy)A Award	Director	AAward	+55K sh	—	—	55,000
2022-06-08	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,478
2022-06-08	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,478
2022-05-18	DURECT CORPP Purchase	Director	PPurchase	+29.9K sh	$0.41	+$12.2K	100,000
2022-05-16	DURECT CORPP Purchase	Director	PPurchase	+25.3K sh	$0.39	+$9,811.34	70,089
2022-05-13	DURECT CORPP Purchase	Director	PPurchase	+9,250 sh	$0.40	+$3,700	44,789
2022-05-12	DURECT CORPP Purchase	Director	PPurchase	+1,500 sh	$0.39	+$585	35,539
2022-05-11	DURECT CORPP Purchase	Director	PPurchase	+9,950 sh	$0.40	+$3,973.035	34,039
2022-05-10	DURECT CORPP Purchase	Director	PPurchase	+2,339 sh	$0.41	+$949.634	24,089
2022-05-10	DURECT CORPP Purchase	Director	PPurchase	+4,250 sh	$0.40	+$1,678.75	21,750
2022-05-09	DURECT CORPP Purchase	Director	PPurchase	+17.5K sh	$0.39	+$6,905.5	17,500
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−30.3K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−45K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−52.5K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−35K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−30K sh	—	—	0
2022-03-07	ZOGENIX, INC.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−40.2K sh	—	—	0
2022-03-07	ZOGENIX, INC.U Disposition from Tender	See Remarks	UDisposition from Tender	−16.6K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−14.3K sh	—	—	0
2021-06-15	DURECT CORPStock Option (right to buy)A Award	Director	AAward	+55K sh	—	—	55,000
2021-06-10	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.4K sh	—	—	17,438
2021-03-26	ZOGENIX, INC.Restricted Stock UnitsA Award	See Remarks	AAward	+15K sh	—	—	15,000
2021-03-26	ZOGENIX, INC.Stock Option (Right to Buy)A Award	See Remarks	AAward	+30K sh	—	—	30,000
2021-03-15	ZOGENIX, INC.F Tax Payment	See Remarks	FTax Payment	−542 sh	$20.70	−$11.2K	14,776
2021-03-15	ZOGENIX, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1,625 sh	—	—	13,109
2021-03-15	ZOGENIX, INC.F Tax Payment	See Remarks	FTax Payment	−587 sh	$20.70	−$12.2K	12,522
2021-03-15	ZOGENIX, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+2,031 sh	—	—	14,553
2021-03-15	ZOGENIX, INC.F Tax Payment	See Remarks	FTax Payment	−735 sh	$20.70	−$15.2K	13,818
2021-03-15	ZOGENIX, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1,500 sh	—	—	15,318
2021-03-15	ZOGENIX, INC.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−1,625 sh	—	—	1,625
2021-03-15	ZOGENIX, INC.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−2,031 sh	—	—	4,062
2021-03-15	ZOGENIX, INC.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−1,500 sh	—	—	4,500
2020-10-19	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+28K sh	—	—	28,000
2020-06-25	ZOGENIX, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+8,750 sh	—	—	14,223

Recent filings

Accepted (ET)
Sep 124
Farfel Gail M0000950170-25-114652
SEC(opens sec.gov)
Sep 114
Farfel Gail M0000950170-25-114319
SEC(opens sec.gov)
Sep 274
Farfel Gail M0000950170-24-110016
SEC(opens sec.gov)
Aug 254
Farfel Gail M0000950170-23-044583
SEC(opens sec.gov)
Jun 234
Farfel Gail M0001209191-23-039470
SEC(opens sec.gov)
Jun 84
Farfel Gail M0001127602-23-018286
SEC(opens sec.gov)
Dec 164
Farfel Gail M0001374339-22-000004
SEC(opens sec.gov)
Dec 84
Farfel Gail M0001374339-22-000003
SEC(opens sec.gov)
Sep 204
Farfel Gail M0001062993-22-019774
SEC(opens sec.gov)
Jun 174
Farfel Gail M0001209191-22-037827
SEC(opens sec.gov)
Jun 104
Farfel Gail M0001127602-22-017243
SEC(opens sec.gov)
May 184
Farfel Gail M0001209191-22-030286
SEC(opens sec.gov)

Companies

Address

C/O MARINUS PHARMA INC 3 RADNOR CORP CENTER 100 MATSONFORD RD, STE 304

RADNOR, PA, 19087